ArticleRadiation oncology (London, England)2025
Elevated MS4A12 expression is indicative of resistance to concurrent chemoradiotherapy and inferior survival in patients with rectal cancer.
Chih-I Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.